Michael Recht

Eptacog Beta Efficacy and Safety in the Treatment and Control of Bleeding in Paediatric Subjects (<12 Years) with Hemophilia A or B with Inhibitors

Author(s):

Steven W Pipe, Cédric Hermans, Meera Chitlur, Manuel Carcao , Giancarlo Castaman, Joanna A Davis, Jonathan Ducore, Amy L Dunn, Miguel Escobar, Janna Journeycake, Osman Khan, Johnny Mahlangu, Shannon L Meeks, Ismail Haroon Mitha, Claude Négrier, Ulrike Nowak-Göttl, Michael Recht, Tammuella Chrisentery-Singleton, Oleksandra Stasyshyn, Kateryna V Vilchevska, Laura Villarreal Martinez, Michael Wang, Jerzy Windyga, Guy Young, W Allan Alexander, Daniel Bonzo, Christopher Macie, Ian S Mitchell, Evelyne Sauty, Thomas A Wilkinson, Amy D Shapiro
Publication:
Haemophilia 
Date:
April 27, 2022
Topics:
Eptacog beta, Factor VII, 12 years and older

Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders

Author(s):

Leonard Valentino, Judith R Baker, Regina Butler, Miguel Escobar, Neil Frick, Susan Karp, Kollet Koulianos, Susan Lattimore, Diane Nugent, Joseph N Pugliese, Michael Recht, Mark T Reding, Michelle Rice, Constance B Thibodeaux, Mark Skinner
Publication:
Journal of Blood Medicine
Date:
October 21, 2021
Topics:
Hemophilia, Integrated Care, HTCs

Patient Preferences and Priorities for Haemophilia Gene Therapy in the US: A Discrete Choice Experiment

Author(s):

Michelle Witkop, George Morgan, Jamie O’Hara, Michael Recht, Tyler Buckner, Diane Nugent, Randall Curtis, Brian O’Mahony, Mark Skinner, Brendan Mulhern, Matthew Cawson, Talaha Ali, Eileen Sawyer, Nanxin Li
Publication:
Haemophilia
Date:
September 1, 2021
Topics:
Discrete Experiment, Patient preference, Hemophilia, Gene therapy

Adult Lifetime Cost of Hemophilia B Management in the US: Payer and Societal Perspectives from a Decision Analytic Model

Author(s):

Nanxin Li , Eileen K. Sawyer, Konrad Maruszczyk, Greg Guzauskas, Marta T Slomka, Tom Burke, Antony P Martin, Jamie O’Hara, Matt Stevenson, Michael Recht
Publication:
Journal of Medical Economics
Date:
Jan-Dec 2021
Topics:
Lifetime cost, SOC (Standard of care), Hemophilia B, Societal Perspectives

The Critical Need for Postmarketing Surveillance in Gene Therapy for Haemophilia

Author(s):

Barbara A Konkle, Michael Recht, Anneliese Higer, Peter Marks
Publication:
Haemophilia
Date:
June 3, 2020
Topics:
Post-marketing, Gene therapy, Hemophilia

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.